All Insights
UK Supreme Court upholds appeal by biotech firm Kymab to revoke antibody patents held by US giant Regeneron
Judgment overturns the Court of Appeal's decision on ground-breaking technology, rebalances the legal equilibrium on sufficiency, and grants reprieve to
Coronavirus Legal Briefing | The activist state
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times. In this edition
Government guidance on responsible contractual behaviour
Overview and analysis of the new guidance from The Cabinet Office and the Infrastructure and Projects Authority
Telemedicine on the rise in Europe
The European telemedicine industry is on the rise as a result of recent legalisation of activities such as remote treatment
CJEU clarifies conditions for obtaining SPC protection for medicinal products
Royalty Pharma: the CJEU's latest decision on Supplementary Protection Certificates addresses when medicinal products can be "protected by a basic
Proposal to amend the Good Governance Code of Listed Companies
The Spanish National Securities Market Commission (the "CNMV") is expected to approve, at the end of the first semester of
Coronavirus Legal Briefing | The latest on the UK government's funding schemes for business
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
Coronavirus Legal Briefing | The EU's exit strategy for business
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
Coronavirus Legal Briefing | What we're seeing
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
